Morphine- and anandamide-stimulated nitric oxide production inhibits presynaptic dopamine release

Brain Research

Volumn 763, Issue 1, 1997, Pages 63-68

  Stefano, George B ^a,c   Salzet, Beatrice ^c   Rialas, Christos M ^a   Pope, McElvin ^a   Kustka, Adam ^b   Neenan, Kevin ^a   Pryor, Stephen ^a   Salzet, Michel ^a,c  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c UNIV LILLE   (France)

Author keywords

Anandamide; Dopamine; Invertebrate ganglia; Morphine; Presynaptic release; Serotonin

Indexed keywords

ANANDAMIDE; DOPAMINE; MORPHINE; NITRIC OXIDE; SEROTONIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; GANGLION; LEECH; MUSSEL; NEUROMODULATION; NONHUMAN; PRESYNAPTIC MEMBRANE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; ARACHIDONIC ACIDS; CANNABINOIDS; DOPAMINE; GANGLIA, INVERTEBRATE; LEECHES; MORPHINE; NITRIC OXIDE; POLYUNSATURATED ALKAMIDES; PRESYNAPTIC TERMINALS;

EID: 0030768086     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00403-4     Document Type: Article

References (29)

1. M.D. Black, E.K. Matthews, P.P. Humphrey, The effects of a photosensitive nitric oxide donor on basal and electrically-stimulated dopamine efflux from the rat striatum in vitro, Neuropharmacology 33 (1994) 1357-1365.
2. D.E. Burrell, G.B. Stefano, Analysis of monoamine accumulations in the neuronal tissues of Mytilus edulis (bivalvia) I. Ganglionic variations, Comp. Biochem. Physiol. 170C (1981) 71-76.
3. O. Bugnon, N.C. Schaad, M. Schorderet, Nitric oxide modulates endogenous dopamine release in bovine retina, NeuroReport 5 (1994) 401-404.
4. 3H]-dopamine from striatal slices, NeuroReport 3 (1992) 409-412.
5. A.C. Hewlett, M. Bidaut-Russell, W.A. Devane, L.S. Melvin, M.R. Johnson, M. Herkenham, The cannabinoid receptor: biochemical, anatomical and behavior characterization, Trends Neurosci. 13 (1990) 420-423.
6. M.A. Klitenick, P.W. Kalivas, Behavioral and neurochemical studies of opioid effects in the pedunculopontine nucleus and mediodorsal thalamus, J. Pharmacol. Exp. Ther. 269 (1994) 437-448.
7. E.J.N. Ishac, L. Jiang, K.D. Lake, K. Varga, M.E. Abood, G. Kunos, Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves, Br. J. Pharmacol. 118 (1996) 2023-2028.
8. A.M. Lin, L.S. Kao, C.Y. Chai, Involvement of nitric oxide in dopaminergic transmission in rat striatum: an in vivo electrochemical study, J. Neurochem. 65 (1995) 2043-2049.
9. Y. Liu, D. Shenouda, T.V. Bilfinger, M.L. Stefano, H.I. Magazine, G.B. Stefano, Morphine stimulates nitric oxide release from invertebrate microglia, Brain Res. 722 (1996) 125-131.
10. 3H]-dopamine release from striatal slices, J. Neurosci. Res. 35 (1993) 192-198.
11. D.S. Lorrain, E.M. Hull, Nitric oxide increases dopamine and serotonin release in the medial preoptic area, NeuroReport 5 (1993) 87-89.
12. H. Macarthur, M.B. Mattammal, T.C. Westfall, A new perspective on the inhibitory role of nitric oxide in sympathetic neurotransmission, Biochem. Biophys. Res. Commun. 216 (1995) 686-692.
13. H.I. Magazine, Detection of endothelial cell-derived nitric oxide: current trends and future directions, Adv. Neuroimmunol. 5 (1995) 479-485.
14. H.I. Magazine, Y. Liu, T.V. Bilfinger, G.L. Fricchione, G.B. Stefano, Morphine-induced conformational changes in immunocytes, endothelial cells and microglia are mediated by nitric oxide, J. Immunol. 156 (1996) 4845-4850.
15. R.G. Pertwee, S.R. Fernando, Evidence for the presence of cannabinoid CB1 receptors in mouse urinary bladder, Br. J. Pharmacol. 118 (1996) 2053-2058.
16. R.G. Pertwee, S.R. Fernando, J.E. Nash, A.A. Coutts, Further evidence for the presence of cannabinoid CBI receptors in guinea-pig small intestine, Br. J. Pharmacol. 118 (1996) 2199-2205.
17. N.T. Sandor, A. Brassai, A. Puskas, B. Lendvai, Role of nitric oxide in modulating neurotransmitter release from rat striatum, Brain Res. Bull. 36 (1995) 483-486.
18. B. Schlosser, M.B. Kudernatsch, B. Sutor, G. ten Bruggencate, Delta, mu and kappa opioid receptor agonists inhibit dopamine overflow in rat neostriatal slices, Neurosci. Lett. 191 (1995) 126-130.
19. A. Seilicovich, M. Lasaga, M. Befumo, B.H. Duvilanski, M. del Carmen Diaz, V. Rettori, S.M. McCann, Nitric oxide inhibits the release of norepinephrine and dopamine from the medial hypothalamus of the rat, Proc. Natl. Acad. Sci. USA 92 (1995) 11299-11302.
20. 3H]dopamine release from rat ventral mesencephalic dissociated cell cultures, Mol. Pharmacol. 42 (1992) 575-583.
21. G.B. Stefano, B. Hall, M.H. Makman, B. Dvorkin, Opioids inhibit potassium-stimulated dopamine release in the marine mussel Mytilus edulis and in the cephalopod, Octopus bimaculatus, Science 213 (1981) 928-930.
22. G.B. Stefano, Comparative aspects of opioid-dopamine interaction, Cell. Mol. Neurobiol. 2 (1982) 167-178.
23. G.B. Stefano, M. Teoh, A. Grant, C. Reid, H. Teoh, T.K. Hughes, In vitro effects of electromagnetic fields on immunocytes, Electro-Magnetobiology 13 (1994) 123-136.
24. 3 opiate receptor in endothelial cells: coupling to nitric oxide production and vasodilation, J. Biol. Chem. 270 (1995) 30290-30293.
25. G.B. Stefano, Y. Liu, M.S. Goligorsky, Cannabinoid receptors are coupled to nitric oxide release in invertebrate immunocytes, microglia and human monocytes, J. Biol. Chem. 271 (1996) 19238-19242.
26. G.B. Stefano, B. Scharrer, E.M. Smith, T.K. Hughes, H.I. Magazine, T.V. Bilfinger, A.R. Hartman, G.L. Fricchione, Y. Liu, M.H. Makman, Opioid and opiate immunoregulatory processes, Crit. Rev. Immunol., 16 (1996) 109-143.
27. G.B. Stefano, B. Salzet, M. Salzet, Identification and characterization of the Leech CNS cannabinoid receptor: coupling to nitric oxide release, Brain Res., 753 (1997) 219-224.
28. 3H]-norepinephrine from rat hippocampal slices, Neuropharmacology 33 (1994) 1367-1374.
29. P. Sun, A. Kanthasamy, G.K. Yim, G.E. Isom, Inhibition of potassium-stimulated dopamine release by the nitric oxide generator isosorbide dinitrate, Neuropharmacology 34 (1995) 205-210.